P3-034: Detection of gender specific differences in the diagnosis of Alzheimer's disease via high-resolution blood-gene expression

2009 ◽  
Vol 5 (4S_Part_12) ◽  
pp. P350-P350
Author(s):  
Richard Einstein ◽  
Pascale Fehlbaum-Beurdeley ◽  
Anne-Charlotte Jarrige-Le Prado ◽  
Weiyin Zhou ◽  
Olivier Sol ◽  
...  
2010 ◽  
Vol 6 (1) ◽  
pp. 25-38 ◽  
Author(s):  
Pascale Fehlbaum-Beurdeley ◽  
Anne Charlotte Jarrige-Le Prado ◽  
Diego Pallares ◽  
Jennifer Carrière ◽  
Caroline Guihal ◽  
...  

2019 ◽  
Vol 84 ◽  
pp. 98-108 ◽  
Author(s):  
Elaheh Moradi ◽  
Mikael Marttinen ◽  
Tomi Häkkinen ◽  
Mikko Hiltunen ◽  
Matti Nykter

2015 ◽  
Vol 53 (9) ◽  
pp. 5902-5911 ◽  
Author(s):  
Anna Antonell ◽  
Albert Lladó ◽  
Raquel Sánchez-Valle ◽  
Coral Sanfeliu ◽  
Teresa Casserras ◽  
...  

2021 ◽  
Author(s):  
Hamed Taheri Gorji ◽  
Ramtin Kardan ◽  
Neda Rezagholizadeh

Alzheimer's Disease (AD) is a progressive neurodegenerative disorder and the most commonly diagnosed cause of dementia, and it is the fifth leading cause of death among people aged 65 and older. During the years, the early diagnosis of AD patients has been a significant concern for researchers, in view of the fact that early diagnosis not only can lead to saving lives of the AD patients but also could bring a considerable amount of saving in health and long-term care expenditures for both people and the government. Mild cognitive impairment (MCI), defined as a transitional state between being healthy and having AD, is considered an established risk factor for AD. Hence, an accurate and reliable diagnosis of MCI and, consequently, discrimination between healthy people, MCI individuals, and AD patients can play a crucial role in the early diagnosis of AD. In recent years, analysis of blood gene expression data has been grabbed more attention than the conventional AD diagnosis method because it provides the opportunity to investigate the biochemical pathways, cellular functions, and regulatory mechanisms for finding the key genes associated with MCI and AD. Therefore, in this study, we employed blood gene expression data from Alzheimer's Disease Neuroimaging Initiative (ADNI), two feature selection methods for determining the most prominent genes related to MCI and AD, and three classifiers for the most accurate discrimination between three groups of healthy, MCI and AD. The proposed method yielded the selection of top ten genes from more than 49,000 genes and the best overall classification result between healthy and AD patients with average values of the area under the curve (AUC) of 0.77 +- 0.08. Furthermore, gene ontology (GO) analysis revealed that four genes were enriched with the GO terms of regulation of cell proliferation, negative regulation of cell population proliferation, signaling receptor binding, biological adhesion, and cytokine production.


2011 ◽  
Vol 7 ◽  
pp. e13-e14
Author(s):  
Angela Hodges ◽  
Katie Lunnon ◽  
Simon Furney ◽  
Petroula Proitsi ◽  
Martina Sattlecker ◽  
...  

2013 ◽  
Vol 33 (3) ◽  
pp. 737-753 ◽  
Author(s):  
Katie Lunnon ◽  
Martina Sattlecker ◽  
Simon J. Furney ◽  
Giovanni Coppola ◽  
Andrew Simmons ◽  
...  

2016 ◽  
Vol 12 ◽  
pp. P448-P448
Author(s):  
Mariet Allen ◽  
Xue Wang ◽  
Jeremy D. Burgess ◽  
Thuy Nguyen ◽  
Kimberly G. Malphrus ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document